| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/26/2000 | EP1021547A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 07/26/2000 | EP1021545A2 Dengue virus antigens and treatment of dengue fever |
| 07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
| 07/26/2000 | EP1021534A1 Hepatitis c receptor protein cd81 |
| 07/26/2000 | EP1021526A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 07/26/2000 | EP1021445A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 07/26/2000 | EP1021443A1 Hemoregulatory compounds |
| 07/26/2000 | EP1021439A1 Crystalline antifungal polymorph |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021404A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021209A1 Inactivation of viruses by incubation with caprylate |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 07/26/2000 | EP1021188A1 Inhibitors of prenyl-protein transferase |
| 07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 07/26/2000 | EP1021180A1 Mixed cyanoacrylate ester compositions |
| 07/26/2000 | EP1021176A1 Cobalt schiff base compounds |
| 07/26/2000 | EP0769054B1 Immunomodulators |
| 07/26/2000 | EP0759775B1 Ifn-beta liquid formulations |
| 07/26/2000 | EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 07/26/2000 | EP0556319B1 Sampangine derivatives useful as antifungal agents |
| 07/26/2000 | CN1261287A Pharmaceutical formulations containing voriconazole |
| 07/26/2000 | CN1261283A Multivalent in ovo avian vaccine |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1054758C Medicine bar for fumigation |
| 07/26/2000 | CN1054752C Anti-virus heat-cleaning oral liquid |
| 07/26/2000 | CN1054750C Compound garlic oil capsule and its producing method |
| 07/26/2000 | CN1054745C Antibiotic composition |
| 07/26/2000 | CA2296965A1 Use of bacterium for manufacture of a vaccine |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093814 Process for preparation of cefdinir |
| 07/25/2000 | US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells |
| 07/25/2000 | US6093741 Agents with leukotriene B4-like activity as antiherpes viral agents |
| 07/25/2000 | US6093736 Antibacterial agents |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093564 Methods and compositions for the selective modification of nucleic acids |
| 07/25/2000 | US6093405 Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines |
| 07/25/2000 | US6093400 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/25/2000 | US6093394 Vaginal lactobacillus medicant |
| 07/25/2000 | US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor |
| 07/25/2000 | CA2167688C Methods and compositions for inhibiting uridine secretion |
| 07/25/2000 | CA2141029C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 07/25/2000 | CA2094611C Hiv immunotherapeutics |
| 07/25/2000 | CA2015377C Autoantibodies which enhance the rate of a chemical reaction |
| 07/20/2000 | WO2000042429A2 In vitro model for gastrointestinal inflammation |
| 07/20/2000 | WO2000042192A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/20/2000 | WO2000042186A1 NOVEL INTERFERON-$g(a) |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042068A2 Hiv related peptides |
| 07/20/2000 | WO2000042065A1 Pseudopeptide, synthesis method, reagent and applications |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | WO2000042058A1 Steroid derived antibiotics |
| 07/20/2000 | WO2000042056A1 Method for preparing an aza-macrolide with 4'' (r) nh¿2? |
| 07/20/2000 | WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use |
| 07/20/2000 | WO2000042045A2 Functionalized heterocycles as chemokine receptor modulators |
| 07/20/2000 | WO2000042043A1 PYRROLO[2,3-d]PYRIMIDINES AS ANTIVIRAL AGENTS |
| 07/20/2000 | WO2000042041A1 Carbapenem ester compounds |
| 07/20/2000 | WO2000042029A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041724A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 07/20/2000 | WO2000041703A1 Administration of an anti-endotoxin drug by intravenous infusion |
| 07/20/2000 | WO2000041688A1 Use of an amiodarone compound as antifungal agent |
| 07/20/2000 | WO2000041682A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041547A2 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide |
| 07/20/2000 | WO2000041528A2 Improved controlled release compositions and method |
| 07/20/2000 | WO2000041514A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO2000041473A2 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections |
| 07/20/2000 | WO2000041463A2 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | WO2000016732A3 ANTI-MICROBIAL-ADHESION FRACTION DERIVED FROM $i(VACCINIUM) |
| 07/20/2000 | WO2000013649A3 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
| 07/20/2000 | WO2000003709A9 Novel dna-cleaving antitumor agents |
| 07/20/2000 | WO2000003030A3 Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2724287A1 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2372197A1 Functionalized heterocycles as chemokine receptor modulators |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360563A1 Novel interferon-.alpha. |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |